potentially important times, page-29

just rec'd an attached page 'A company overview' along with my Computershare docs on becoming a shareholder. Among many other things it says the following about ATC:

'The design and preparations for the pivotal Phase 111 clinical trials for Avexa's ATC development program have been finalised and an accelerated review with a 24 week end point has been agreed with the FDA. These trials will strengthen and confirm the Phase 11b data showing that ATC is the best drug in its class for treatment of patients with resistant HIV'.


dyor